{"transactions":[{"id":1719400,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":107699,"kind":"person","name":"Glynn Craig","position":1,"cik":"0001809590","reported_name":"Glynn Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2023-12-07T17:07:03.000Z","date":"2023-12-05","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2026."}],"balance_after":75000,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-23-044062","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809590/000149315223044062/ownership.xml","form_type":"4"}},{"id":2489667,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":107699,"kind":"person","name":"Glynn Craig","position":1,"cik":"0001809590","reported_name":"Glynn Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2021-12-02T18:25:16.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":125925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2024."}],"balance_after":125925,"derivative":{"exercise_price":6.7,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":125925},"source":{"system":"sec-edgar","filing":"0001493152-21-030331","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1809590/000149315221030331/ownership.xml","form_type":"4"}},{"id":2489666,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":107699,"kind":"person","name":"Glynn Craig","position":1,"cik":"0001809590","reported_name":"Glynn Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-02T18:25:16.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted 50,000 restricted stock units on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The restricted stock units are subject to milestone-based vesting as follows: (i) 50% upon SAVVE (Surgical Anti-reflux Venous Valve Endoprosthesis) endpoints being achieved, and (ii) 50% upon the Pre-Market Approval of the VenoValve."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001493152-21-030331","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809590/000149315221030331/ownership.xml","form_type":"4"}},{"id":2841021,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":107699,"kind":"person","name":"Glynn Craig","position":1,"cik":"0001809590","reported_name":"Glynn Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2021-02-23T17:21:15.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":324000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest in equal quarterly installments over a three year period, however the stock options may only become exercisable following receipt by the registrant of stockholder approval to increase the size of the Plan sufficiently to permit the exercise in full of such stock options under the Plan. If the registrant's stockholders do not approve an increase in the size of the Plan, the options will be void."}],"balance_after":324,"derivative":{"exercise_price":8.2,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":324},"source":{"system":"sec-edgar","filing":"0001493152-21-004623","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1809590/000149315221004623/ownership.xml","form_type":"4"}},{"id":2841020,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":107699,"kind":"person","name":"Glynn Craig","position":1,"cik":"0001809590","reported_name":"Glynn Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2021-02-23T17:21:15.000Z","date":"2020-07-18","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in equal quarterly installments over a three year period commencing October 18, 2020."}],"balance_after":4000,"derivative":{"exercise_price":10,"expiration_date":"2030-07-18","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001493152-21-004623","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809590/000149315221004623/ownership.xml","form_type":"4"}}]}